Antibody to telomerase reverse transcriptive
US7750121B2 · kind B2 · utility
4Cited by
62References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 17, 2005 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Dec 18, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.